ZBIO FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm
NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the 'Registration Statement') issued in connection with Zenas BioPharma's September 2024 initial public offering ('IPO' or the 'Offering'), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the firm.
SO WHAT: If you purchased Zenas BioPharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Zenas BioPharma class action, go to https://rosenlegal.com/submit-form/?case_id=37109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Zenas BioPharma action, go to https://rosenlegal.com/submit-form/?case_id=37109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
11 minutes ago
- Bloomberg
Indian Depository NSDL Is Said to Plan $400 Million IPO for July
National Securities Depository Ltd. is pressing ahead with its plan for an initial public offering that is expected to raise about $400 million, according to people familiar with the matter. The proposed listing of India's oldest depository, which was initially cleared by the market regulator in October last year, is now slated to take place as soon as July, according to the people, who asked not to be named as the information is private.
CNN
17 minutes ago
- CNN
Federal appeals court to hear arguments in Trump's long-shot effort to fight hush money conviction
Five months after President Donald Trump was sentenced without penalty in the New York hush money case, his attorneys will square off again with prosecutors Wednesday in one of the first major tests of the Supreme Court's landmark presidential immunity decision. Trump is relying heavily on the high court's divisive 6-3 immunity ruling from July in a long-shot bid to get his conviction reviewed – and ultimately overturned – by federal courts. After being convicted on 34 counts of falsifying business records, Trump in January became the first felon to ascend to the presidency in US history. Even after Trump was reelected and federal courts became flooded with litigation tied to his second term, the appeals in the hush money case have chugged forward in multiple courts. A three-judge panel of the 2nd US Circuit Court of Appeals – all named to the bench by Democratic presidents – will hear arguments Wednesday in one of those cases. Trump will be represented on Wednesday by Jeffrey Wall, a private lawyer and Supreme Court litigator who served as acting solicitor general during Trump's first administration. Many of the lawyers who served on Trump's defense team in the hush money case have since taken top jobs within the Justice Department. The case stems from the 2023 indictment announced by Manhattan District Attorney Alvin Bragg, a Democrat, who accused Trump of falsely categorizing payments he said were made to quash unflattering stories during the 2016 election. Trump was accused of falsifying a payment to his former lawyer, Michael Cohen, to cover up a $130,000 payment Cohen made to adult-film star Stormy Daniels to keep her from speaking out before the 2016 election about an alleged affair with Trump. (Trump has denied the affair.) Trump was ultimately convicted last year and was sentenced without penalty in January, days before he took office. The president is now attempting to move that case to federal court, where he is betting he'll have an easier shot at arguing that the Supreme Court's immunity decision in July will help him overturn the conviction. Trump's earlier attempts to move the case to federal court have been unsuccessful. US District Judge Alvin Hellerstein, nominated by President Bill Clinton, denied the request in September – keeping Trump's case in New York courts instead. The 2nd Circuit will now hear arguments on Trump's appeal of that decision on Wednesday. 'He's lost already several times in the state courts,' said David Shapiro, a former prosecutor and now a lecturer at John Jay College of Criminal Justice. And Trump's long-running battle with New York Judge Juan Merchan, Shapiro said, has 'just simmered up through the system' in New York courts in a way that may have convinced Trump that federal courts will be more receptive. Trump, who frequently complained about Merchan, has said he wants his case heard in an 'unbiased federal forum.' Trump's argument hangs largely on a technical but hotly debated section of the Supreme Court's immunity decision last year. Broadly, that decision granted former presidents 'at least presumptive' immunity for official acts and 'absolute immunity' when presidents were exercising their constitutional powers. State prosecutors say the hush money payments were a private matter – not official acts of the president – and so they are not covered by immunity. But the Supreme Court's decision also barred prosecutors from attempting to show a jury evidence concerning a president's official acts, even if they are pursuing alleged crimes involving that president's private conduct. Without that prohibition, the Supreme Court reasoned, a prosecutor could 'eviscerate the immunity' the court recognized by allowing a jury to second-guess a president's official acts. Trump is arguing that is exactly what Bragg did when he called White House officials such as former communications director Hope Hicks and former executive assistant Madeleine Westerhout to testify at his trial. Hicks had testified that Trump felt it would 'have been bad to have that story come out before the election,' which prosecutors later described as the 'nail' in the coffin of the president's defense. Trump's attorneys are also pointing to social media posts the president sent in 2018 denying the Daniels hush money scheme as official statements that should not have been used in the trial. State prosecutors 'introduced into evidence and asked the jury to scrutinize President Trump's official presidential acts,' Trump's attorneys told the appeals court in a filing last month. 'One month after trial, the Supreme Court unequivocally recognized an immunity prohibiting the use of such acts as evidence at any trial of a former president.' A White House spokesperson did not respond to a request for comment. If Trump's case is ultimately reviewed by federal courts, that would not change his state law conviction into a federal conviction. Trump would not be able to pardon himself just because a federal court reviews the case. Bragg's office countered that it's too late for federal courts to intervene. Federal officials facing prosecution in state courts may move their cases to federal court in many circumstances under a 19th century law designed to ensure states don't attempt to prosecute them for conduct performed 'under color' of a US office or agency. A federal government worker, for instance, might seek to have a case moved to federal court if they are sued after getting into a car accident while driving on the job. But in this case, Bragg's office argued, Trump has already been convicted and sentenced. That means, prosecutors said, there's really nothing left for federal courts to do. 'Because final judgment has been entered and the state criminal action has concluded, there is nothing to remove to federal district court,' prosecutors told the 2nd Circuit in January. Even if that's not true, they said, seeking testimony from a White House adviser about purely private acts doesn't conflict with the Supreme Court's ruling in last year's immunity case. Bragg's office has pointed to a Supreme Court ruling as well: the 5-4 decision in January that allowed Trump to be sentenced in the hush money case. The president raised many of the same concerns about evidence when he attempted to halt that sentencing before the inauguration. A majority of the Supreme Court balked at that argument in a single sentence that, effectively, said Trump could raise those concerns when he appeals his conviction. That appeal remains pending in state court. 'The alleged evidentiary violations at President-elect Trump's state-court trial,' the Supreme Court wrote, 'can be addressed in the ordinary course on appeal.'
Wall Street Journal
34 minutes ago
- Wall Street Journal
Global Markets Mostly Higher; U.S. Futures Down Ahead of Inflation Data
Global markets were mostly higher and U.S. stock futures were lower after U.S and China officials hit the reset button following two days of trade talks, and ahead of the U.S. CPI inflation report due later Wednesday. Little detail from the talks was released, but representatives from the countries said the framework agreed would essentially restore a pact they agreed to in Switzerland last month, a deal that saw both sides lower tariffs.
